• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Potassium Trajectories prior to Dialysis and Mortality following Dialysis Initiation in Patients with Advanced CKD.晚期慢性肾脏病患者透析前的钾轨迹与透析启动后的死亡率。
Nephron. 2021;145(3):265-274. doi: 10.1159/000514294. Epub 2021 Mar 22.
2
Predialysis Potassium Variability and Postdialysis Mortality in Patients With Advanced CKD.晚期慢性肾脏病患者透析前血钾变异性与透析后死亡率
Kidney Int Rep. 2021 Jan 14;6(2):366-380. doi: 10.1016/j.ekir.2020.11.022. eCollection 2021 Feb.
3
Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis.慢性肾脏病晚期进入透析患者的非akalemia 与缺血性卒中的相关性。
Am J Nephrol. 2021;52(7):539-547. doi: 10.1159/000516902. Epub 2021 Jul 21.
4
Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.终末期肾病前血红蛋白变异性预测透析转换患者终末期肾病后死亡率。
Am J Nephrol. 2017;46(5):397-407. doi: 10.1159/000484356. Epub 2017 Nov 7.
5
Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.在进入透析的晚期慢性肾脏病患者中,终末期肾病前血清碱性磷酸酶对终末期肾病后死亡率的预后意义。
Nephrol Dial Transplant. 2018 Feb 1;33(2):264-273. doi: 10.1093/ndt/gfw412.
6
Association of Pre-ESRD Serum Bicarbonate with Post-ESRD Mortality in Patients with Incident ESRD.血清碳酸氢盐与终末期肾病患者的终末期肾病后死亡率的相关性。
Am J Nephrol. 2021;52(4):304-317. doi: 10.1159/000513855. Epub 2021 Apr 23.
7
Mortality Risk in Chronic Kidney Disease Patients Transitioning to Dialysis: Impact of Opiate and Non-Opiate Use.慢性肾脏病患者进入透析阶段的死亡风险:阿片类药物和非阿片类药物使用的影响。
Am J Nephrol. 2020;51(9):715-725. doi: 10.1159/000509451. Epub 2020 Aug 10.
8
Association of thyroid status prior to transition to end-stage renal disease with early dialysis mortality.甲状腺功能在终末期肾病前与早期透析死亡率的关系。
Nephrol Dial Transplant. 2019 Dec 1;34(12):2095-2104. doi: 10.1093/ndt/gfy289.
9
Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.高钾血症与晚期慢性肾脏病临床结局的关联
Nefrologia (Engl Ed). 2019 Sep-Oct;39(5):513-522. doi: 10.1016/j.nefro.2019.01.007. Epub 2019 Apr 23.
10
Association of dyskalemias with short-term health care utilization in patients with advanced CKD.低钙血症与晚期 CKD 患者短期医疗保健利用的关系。
J Manag Care Spec Pharm. 2021 Oct;27(10):1403-1415. doi: 10.18553/jmcp.2021.27.10.1403.

引用本文的文献

1
Management of hyperkalemia: strategic clinical actions in real-world practice.高钾血症的管理:现实临床实践中的策略性临床行动
Clin Exp Nephrol. 2025 Jul 24. doi: 10.1007/s10157-025-02728-2.
2
Pathophysiology and causes of hyperkalemia: unraveling causes beyond kidney dysfunction.高钾血症的病理生理学与病因:揭示肾功能不全以外的病因
Clin Exp Nephrol. 2025 Jun 11. doi: 10.1007/s10157-025-02711-x.
3
Machine learning approaches for the mortality risk assessment of patients undergoing hemodialysis.用于接受血液透析患者死亡风险评估的机器学习方法
Ther Adv Chronic Dis. 2022 Aug 30;13:20406223221119617. doi: 10.1177/20406223221119617. eCollection 2022.
4
Patterns of chronic and transient hyperkalaemia and clinically important outcomes in patients with chronic kidney disease.慢性肾脏病患者慢性和短暂性高钾血症模式及临床重要结局
Clin Kidney J. 2021 Sep 4;15(1):153-161. doi: 10.1093/ckj/sfab159. eCollection 2022 Jan.
5
Association of dyskalemias with short-term health care utilization in patients with advanced CKD.低钙血症与晚期 CKD 患者短期医疗保健利用的关系。
J Manag Care Spec Pharm. 2021 Oct;27(10):1403-1415. doi: 10.18553/jmcp.2021.27.10.1403.
6
Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis.慢性肾脏病晚期进入透析患者的非akalemia 与缺血性卒中的相关性。
Am J Nephrol. 2021;52(7):539-547. doi: 10.1159/000516902. Epub 2021 Jul 21.

本文引用的文献

1
Fluctuations in plasma potassium in patients on dialysis.透析患者血浆钾的波动。
Nephrol Dial Transplant. 2019 Dec 1;34(Suppl 3):iii19-iii25. doi: 10.1093/ndt/gfz209.
2
Effect of Dietary Potassium Restriction on Serum Potassium, Disease Progression, and Mortality in Chronic Kidney Disease: A Systematic Review and Meta-Analysis.膳食钾限制对慢性肾脏病患者血清钾、疾病进展和死亡率的影响:系统评价和荟萃分析。
J Ren Nutr. 2020 Jul;30(4):276-285. doi: 10.1053/j.jrn.2019.09.009. Epub 2019 Nov 14.
3
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.肾脏疾病中的钾离子稳态和血钾紊乱管理:KDIGO 争议会议的结论。
Kidney Int. 2020 Jan;97(1):42-61. doi: 10.1016/j.kint.2019.09.018. Epub 2019 Oct 10.
4
Statin Therapy Before Transition to End-Stage Renal Disease With Posttransition Outcomes.在进入终末期肾病之前进行他汀类药物治疗与过渡期后结局。
J Am Heart Assoc. 2019 Mar 19;8(6):e011869. doi: 10.1161/JAHA.118.011869.
5
US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2018年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21.
6
Acute kidney injury following coronary revascularization procedures in patients with advanced CKD.慢性肾脏病晚期患者冠状动脉血运重建术后急性肾损伤。
Nephrol Dial Transplant. 2019 Nov 1;34(11):1894-1901. doi: 10.1093/ndt/gfy178.
7
Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes: A Danish Population-Based Cohort Study.充血性心力衰竭患者血钾水平升高:发生率、危险因素和临床结局:一项丹麦基于人群的队列研究。
J Am Heart Assoc. 2018 May 22;7(11):e008912. doi: 10.1161/JAHA.118.008912.
8
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.血清钾与肾功能范围内的不良结局:CKD 预后联盟荟萃分析。
Eur Heart J. 2018 May 1;39(17):1535-1542. doi: 10.1093/eurheartj/ehy100.
9
Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function.饮食控制复发性或慢性肾功能减退患者高钾血症。
Nutrients. 2018 Feb 25;10(3):261. doi: 10.3390/nu10030261.
10
Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study.慢性肾脏病患者血钾水平升高:一项丹麦基于人群的队列研究中的发生、危险因素和临床结局。
Nephrol Dial Transplant. 2018 Sep 1;33(9):1610-1620. doi: 10.1093/ndt/gfx312.

晚期慢性肾脏病患者透析前的钾轨迹与透析启动后的死亡率。

Potassium Trajectories prior to Dialysis and Mortality following Dialysis Initiation in Patients with Advanced CKD.

机构信息

Institute for Health Outcomes and Policy, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

出版信息

Nephron. 2021;145(3):265-274. doi: 10.1159/000514294. Epub 2021 Mar 22.

DOI:10.1159/000514294
PMID:33752200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8102350/
Abstract

INTRODUCTION

Patients with advanced non-dialysis-dependent CKD (NDD-CKD) have a reduced ability for maintaining plasma potassium (K) in normal range. Deviation from normal plasma K ranges is associated with increased mortality; however, the average trajectory of plasma K over time in patients with advanced NDD-CKD and the outcomes associated with plasma K trajectory are unknown.

METHODS

We identified 34,167 US veterans with advanced NDD-CKD transitioning to dialysis between October 2007 and March 2015 with at least 1 K measurement each year over a 3-year period prior to dialysis transition (3-year prelude). The K trajectory defined as the change in K (slope) per year over the entire 3-year prelude was estimated using linear mixed-effects models. The association between unadjusted (crude) K slope (categorized as stable [-0.09 to 0.09 mEq/L/year], decreasing [≤-0.10 mEq/L/year], and increasing [≥0.10 mEq/L/year]) and time to all-cause and cardiovascular mortality during the 6 months following dialysis initiation was assessed using multivariable-adjusted survival models.

RESULTS

The crude and multivariable-adjusted K slopes (mean, 95% CI) over the 3-year prelude were 0.008 (0.0059, 0.0110) and -0.15 mEq/L/year (-0.19, -0.11), respectively. Decreasing K slope was associated with higher multivariable-adjusted risk of all-cause mortality (adjusted hazard ratio [95% CI] vs. stable K slope: 1.08 [1.00-1.17]). No association was observed between K slope and cardiovascular mortality.

DISCUSSION/CONCLUSION: The average intraindividual plasma K trajectory is remarkably stable in patients with advanced NDD-CKD. A decreasing K slope is associated with higher all-cause mortality risk.

摘要

简介

患有晚期非透析依赖型慢性肾脏病(NDD-CKD)的患者维持血浆钾(K)正常范围的能力降低。血浆 K 范围的偏离与死亡率增加有关;然而,在接受晚期 NDD-CKD 治疗的患者中,血浆 K 随时间的平均轨迹以及与血浆 K 轨迹相关的结局尚不清楚。

方法

我们确定了 2007 年 10 月至 2015 年 3 月期间向透析过渡的 34167 名美国退伍军人,在透析过渡前的 3 年内(3 年导言期)每年至少有 1 次 K 测量。使用线性混合效应模型估计整个 3 年导言期内 K 变化(斜率)的 K 轨迹。使用多变量调整后的生存模型评估未经调整(粗)K 斜率(分类为稳定[-0.09 至 0.09 mEq/L/年]、降低[≤-0.10 mEq/L/年]和增加[≥0.10 mEq/L/年])与透析开始后 6 个月内全因和心血管死亡率之间的关联。

结果

3 年导言期内的粗和多变量调整 K 斜率(平均值,95%CI)分别为 0.008(0.0059,0.0110)和-0.15 mEq/L/年(-0.19,-0.11)。K 斜率降低与全因死亡率的多变量调整后风险增加相关(与稳定 K 斜率相比,调整后的危险比[95%CI]:1.08[1.00-1.17])。未观察到 K 斜率与心血管死亡率之间的关联。

讨论/结论:晚期 NDD-CKD 患者的个体内血浆 K 平均轨迹非常稳定。K 斜率降低与全因死亡率风险增加相关。